{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:25:29Z","timestamp":1769855129800,"version":"3.49.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Although the implant success rate of left atrial appendage closure (LAAC) has increased and complications have decreased over time, there are still anatomically and technically complicated cases where novel LAA occluders may simplify the procedure and thus might potentially improve the clinical outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to assess the safety and efficacy of the newly designed device with isogenous barbs in LAAC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eight centers in China participated in this prospective study from July 2016 to April 2018. Peri- and post-procedural safety and efficacy were evaluated through scheduled follow-ups and transesophageal echocardiography (TEE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 175 patients with a mean age of 68.4 \u00b1 9.2 years old, a mean CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score of 4.7 \u00b1 1.8, and a mean HAS-BLED score of 3.2 \u00b1 1.3, were included. The device was successfully implanted in 173 patients (98.9%). The device size ranged from 18 to 34 mm. Clinically relevant pericardial effusion (PEF) in the perioperative period, occurred in 3 patients (1.7%). TEE follow-up was available in 167 (96.5%) patients at 12-month. During follow-up, 9 patients suffered serious adverse event: 4 death (2.3%), 1 ischemic stroke (0.6%), and 2 gastro-intestinal bleeding (1.2%) and 2 device-related thrombus (DRT) (1.2%). Estimated annual thromboembolism rate reduced by 90% and estimated annual major bleeding rate reduced by 81% after LAAC with the newly designed device.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The newly designed device with isogenous barbs for LAAC could be performed effectively with a low incidence of adverse events and a high incidence of anatomic closure.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.974994","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T07:09:16Z","timestamp":1662102556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A newly designed disk-lobe occluder with isogenous barbs for left atrial appendage closure: Initial multicenter experience"],"prefix":"10.3389","volume":"9","author":[{"given":"Yuan","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianxian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejiang","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry.","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am College Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: From the prevail and protect AF trials.","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am College Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with watchman in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the ewolution trial.","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.jcin.2017.06.072","article-title":"Percutaneous left atrial appendage closure with the lambre device for stroke prevention in atrial fibrillation: A prospective, multicenter clinical study.","volume":"10","author":"Huang","year":"2017","journal-title":"JACC Cardiovasc Intervent."},{"key":"B5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ccd.22764","article-title":"Left Atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial European experience.","volume":"77","author":"Park","year":"2011","journal-title":"Catheterization Cardiovasc Intervent Off J Soc Cardiac Angiogr Intervent."},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1253\/circj.CJ-17-0412","article-title":"Percutaneous left atrial appendage closure with Lacbes((R)) occluder- a preclinical feasibility study.","volume":"82","author":"Tang","year":"2017","journal-title":"Circ J Off J Jpn Circ Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.4244\/eij-d-19-00442","article-title":"Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure.","volume":"16","author":"Kleinecke","year":"2020","journal-title":"EuroIntervention."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/ccd.25354","article-title":"Amplatzer left atrial appendage occlusion through a patent foramen ovale.","volume":"84","author":"Koermendy","year":"2014","journal-title":"Catheterization Cardiovasc Intervent Off J Soc Cardiac Angiogr Intervent."},{"key":"B9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4244\/EIJV12I1A18","article-title":"Percutaneous left atrial appendage occlusion: The munich consensus document on definitions, endpoints and data collection requirements for clinical studies.","volume":"12","author":"Tzikas","year":"2016","journal-title":"Eurointervention J Europcr Collaborat Work Group Intervent Cardiol Eur Soc Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the bleeding academic research consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","article-title":"Identifying patients at high risk for stroke despite anticoagulation: A comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.","volume":"41","author":"Lip","year":"2010","journal-title":"Stroke."},{"key":"B12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The has-bled (Hypertension, abnormal renal\/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drugs\/alcohol concomitantly) Score.","volume":"57","author":"Lip","year":"2011","journal-title":"J Am College Cardiol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"Left atrial appendage closure versus non-warfarin oral anticoagulation in atrial fibrillation: 4-year outcomes of prague-17.","volume":"79","author":"Osmancik","year":"2021","journal-title":"J Am College Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/europace\/euaa001","article-title":"Clinical outcomes of watchman Vs. amplatzer occluders for left atrial appendage closure (Watch at Laac).","volume":"22","author":"Kleinecke","year":"2020","journal-title":"Europace."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/circulationaha.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet Ide): A randomized, controlled trial.","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: Primary results of the swiss-apero randomized clinical trial.","volume":"145","author":"Galea","year":"2021","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.4244\/eij-d-17-00076","article-title":"Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: Results from the Belgian registry.","volume":"13","author":"Kefer","year":"2018","journal-title":"EuroIntervention."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e005841","DOI":"10.1161\/circinterventions.117.005841","article-title":"Percutaneous left atrial appendage closure is a reasonable option for patients with atrial fibrillation at high risk for cerebrovascular events.","volume":"11","author":"Teiger","year":"2018","journal-title":"Circ Cardiovasc Intervent."},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5603\/CJ.a2017.0017","article-title":"Twelve-month follow-up of left atrial appendage occlusion with amplatzer amulet.","volume":"24","author":"Kleinecke","year":"2017","journal-title":"Cardiol J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.4244\/EIJY15M01-06","article-title":"left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the amplatzer cardiac plug.","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.hrthm.2021.05.017","article-title":"Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedures in the United States.","volume":"18","author":"Munir","year":"2021","journal-title":"Heart Rhythm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/jce.15020","article-title":"Delayed pericardial effusion after left atrial appendage closure with the lambre device: Importance of a fully open umbrella.","volume":"32","author":"Xiao","year":"2021","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","article-title":"The clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation: A protect AF (Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy.","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/ehjci\/jev060037","article-title":"Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.","volume":"16","author":"Saw","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.974994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T07:09:21Z","timestamp":1662102561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.974994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":24,"alternative-id":["10.3389\/fcvm.2022.974994"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.974994","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"974994"}}